Market Cap: $4.43B
LP
LivaNova PLC
LIVN
NASDAQ (NASDAQ Global Select)USD
Market Cap: $4.43B
LivaNova PLC (Ticker: LIVN) has made significant changes to its Board of Directors, which point to a strategic shift in its operational and risk management approaches. The company recently appointed J…
LivaNova's Strong Q4 Performance Signals Innovation and Growth Potential LivaNova PLC announces significant progress with its Q4 earnings, showcasing a robust growth trajectory pivotal to its role in…
LivaNova's Strategic Growth in Neuromodulation and Cardiopulmonary Segments LivaNova PLC showcases significant financial progress in its recent Q4 2025 earnings report, highlighting a solid foundation…
LivaNova Reports Impressive Q4 2025 Earnings, Enhancing Market Position LivaNova PLC reveals its Q4 2025 earnings on February 25, 2026, showcasing a robust performance that underscores the company’s s…
LivaNova PLC: Pioneering Innovations in Medical Technologies LivaNova PLC continues to make significant strides in the medical device industry, focusing on innovative therapies to enhance patient care…
LivaNova PLC’s Commitment to Innovation in Medical Technology LivaNova PLC, a global leader in medical technology, continues to prioritize innovation in its product offerings, particularly in the fiel…
LIVN Nutrition Launches Innovative HMB Fruit Chews for Muscle Health LIVN Nutrition takes a significant step forward in the dietary supplement industry with the launch of its HMB Fruit Chews, a novel…
LIVN Nutrition Unveils Revolutionary HMB Fruit Chews for Muscle Health LIVN Nutrition recently announces the launch of its innovative HMB Fruit Chews, a significant advancement in dietary supplements…
LivaNova's Growth Trajectory: A Positive Outlook for the Future LivaNova PLC, a global leader in medical technology, is experiencing an optimistic shift in market perception as Wolfe Research upgrades…
LivaNova's Strategic Growth Trajectory in Medical Technology LivaNova PLC, a prominent player in the medical technology sector, receives a positive upgrade from Wolfe, who predicts a sustainable organ…
LivaNova Advances VNS Therapy for Treatment-Resistant Depression LivaNova PLC, a prominent player in the medical technology sector, announces the publication of two crucial articles in the journal Bra…
LivaNova Advances VNS Therapy Research for Treatment-Resistant Depression LivaNova PLC (Nasdaq: LIVN), a prominent player in the medical technology sector, makes significant strides in the treatment o…
LivaNova PLC Reports Strong Q3 Performance Amid Strategic Focus LivaNova PLC, a prominent player in the medical technology sector, announces an impressive financial performance for the third quarter o…